Estrone (CAS 53-16-7): Role in Cancer Research and Menopausal Health
Estrone (CAS 53-16-7) is a molecule of profound importance in both cancer research and the understanding of menopausal health. As one of the primary estrogens in post-menopausal women, its levels and influence are closely studied in relation to various health conditions.
In the field of oncology, Estrone plays a significant role in the development and progression of hormone-sensitive cancers, most notably breast, endometrial, and ovarian cancers. Research indicates that elevated levels of Estrone can contribute to the growth of these cancer cells, making it a critical target for therapeutic interventions and a key marker in diagnostic studies. Scientists frequently purchase Estrone to investigate anti-cancer drug efficacy, hormonal therapy outcomes, and the underlying mechanisms of cancer development.
Understanding the fluctuations in Estrone levels during menopause is also vital. As the body's production of estradiol decreases after menopause, Estrone becomes the dominant estrogen. Studying these changes helps in managing menopausal symptoms such as hot flashes, vaginal dryness, and bone loss. Estrone itself can be used in hormone replacement therapies, and research into its precise role informs better treatment strategies for women transitioning through menopause.
The availability of high-purity Estrone from reliable suppliers is therefore essential for researchers in these fields. Whether investigating cellular pathways, testing new drug compounds, or developing diagnostic tools, access to consistent quality Estrone (CAS 53-16-7) is paramount. By providing this critical chemical, we support advancements in cancer treatment and women's health initiatives.
Our commitment as a supplier of Estrone ensures that researchers have access to a dependable and high-quality source for their vital work in understanding and combating hormone-related diseases and managing menopausal health.
In the field of oncology, Estrone plays a significant role in the development and progression of hormone-sensitive cancers, most notably breast, endometrial, and ovarian cancers. Research indicates that elevated levels of Estrone can contribute to the growth of these cancer cells, making it a critical target for therapeutic interventions and a key marker in diagnostic studies. Scientists frequently purchase Estrone to investigate anti-cancer drug efficacy, hormonal therapy outcomes, and the underlying mechanisms of cancer development.
Understanding the fluctuations in Estrone levels during menopause is also vital. As the body's production of estradiol decreases after menopause, Estrone becomes the dominant estrogen. Studying these changes helps in managing menopausal symptoms such as hot flashes, vaginal dryness, and bone loss. Estrone itself can be used in hormone replacement therapies, and research into its precise role informs better treatment strategies for women transitioning through menopause.
The availability of high-purity Estrone from reliable suppliers is therefore essential for researchers in these fields. Whether investigating cellular pathways, testing new drug compounds, or developing diagnostic tools, access to consistent quality Estrone (CAS 53-16-7) is paramount. By providing this critical chemical, we support advancements in cancer treatment and women's health initiatives.
Our commitment as a supplier of Estrone ensures that researchers have access to a dependable and high-quality source for their vital work in understanding and combating hormone-related diseases and managing menopausal health.
Perspectives & Insights
Bio Analyst 88
“As one of the primary estrogens in post-menopausal women, its levels and influence are closely studied in relation to various health conditions.”
Nano Seeker Pro
“In the field of oncology, Estrone plays a significant role in the development and progression of hormone-sensitive cancers, most notably breast, endometrial, and ovarian cancers.”
Data Reader 7
“Research indicates that elevated levels of Estrone can contribute to the growth of these cancer cells, making it a critical target for therapeutic interventions and a key marker in diagnostic studies.”